Clinical trials
Terminated Phase 1 Carcinoma, Squamous Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 2 |
| 3B Pharmaceuticals GmbH | 1 |
| Amgen | 1 |
| Boehringer Ingelheim | 1 |
| Celgene | 1 |
| Georgetown University | 1 |
| Hoffmann-La Roche | 1 |
| ImmunoGen, Inc. | 1 |
| National Cancer Institute (NCI) | 1 |
| Northwell Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Squamous Cell | 18 |
| Head and Neck Neoplasms | 6 |
| Squamous Cell Carcinoma of Head and Neck | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 5 |
| Melanoma | 5 |
| Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Hodgkin Disease | 2 |
| Sarcoma | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.